These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 657544)

  • 1. A two-stage enzymatic method for determination of uric acid and hypoxanthine/xanthine.
    Cunningham SK; Keaveny TV
    Clin Chim Acta; 1978 Jun; 86(2):217-21. PubMed ID: 657544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for determining plasma levels of oxypurines.
    Hayashi TT; Gilling B
    Anal Biochem; 1970 Aug; 36(2):343-51. PubMed ID: 5452957
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases.
    Kock R; Delvoux B; Sigmund M; Greiling H
    Eur J Clin Chem Clin Biochem; 1994 Nov; 32(11):837-42. PubMed ID: 7888480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-performance liquid chromatographic method for the determination of hypoxanthine, xanthine, uric acid and allantoin in serum.
    Kock R; Delvoux B; Greiling H
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):303-10. PubMed ID: 8357939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of guanine, uric acid, hypoxanthine and xanthine in human plasma by reversed-phase high-performance liquid chromatography with amperometric detection.
    Liu Z; Li T; Wang E
    Analyst; 1995 Aug; 120(8):2181-4. PubMed ID: 7677251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of hypoxanthine and xanthine with a PO2 electrode.
    Saugstad OD
    Pediatr Res; 1975 Jul; 9(7):575-9. PubMed ID: 1161346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of uric acid and oxypurines in normal subjects and in gout patients].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probenecid on oxypurines in plasma.
    Yamamoto T; Takahashi S; Suda M; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):510-4. PubMed ID: 2511159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorometric determination of xanthine and hypoxanthine in tissue.
    Sumi T; Umeda Y
    Clin Chim Acta; 1979 Jul; 95(2):291-9. PubMed ID: 583329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased xanthine oxidase activities and increased urinary oxypurines in heterozygotes for hereditary xanthinuria.
    Kawachi M; Kono N; Mineo I; Yamada Y; Tarui S
    Clin Chim Acta; 1990 Apr; 188(2):137-46. PubMed ID: 2379312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos TH
    Am J Med; 1988 Oct; 85(4):533-7. PubMed ID: 3177401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative estimation of uric acid, xanthine, and hypoxanthine in plasma using thin-layer chromatography.
    Orsulak PJ; Haab W; Appleton MD
    Anal Biochem; 1968 Apr; 23(1):156-62. PubMed ID: 5645123
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prednisolone on urate and oxypurine excretion.
    Hisatome I; Ishiko R; Sasaki N; Kotake H; Kobayashi M; Ogino K; Hasegawa J; Yoshida A; Shigemasa C; Mashiba H
    Horm Metab Res; 1991 Oct; 23(10):513-4. PubMed ID: 1761287
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorometric determination of hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography using enzyme reactors.
    Kito M; Tawa R; Takeshima S; Hirose S
    J Chromatogr; 1983 Nov; 278(1):35-42. PubMed ID: 6689328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxanthine, xanthine, and urate in synovial fluid from patients with inflammatory arthritides.
    Gudbjörnsson B; Zak A; Niklasson F; Hällgren R
    Ann Rheum Dis; 1991 Oct; 50(10):669-72. PubMed ID: 1958086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luminol chemiluminescence using xanthine and hypoxanthine as xanthine oxidase substrates.
    Radi R; Rubbo H; Thomson L; Prodanov E
    Free Radic Biol Med; 1990; 8(2):121-6. PubMed ID: 2158934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of tissue oxypurine levels with xanthine dehydrogenase changes in the chick.
    DeLapp NW; Fisher JR
    Biochim Biophys Acta; 1972 May; 269(3):505-14. PubMed ID: 5039546
    [No Abstract]   [Full Text] [Related]  

  • 18. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
    Yamanaka H; Nishioka K; Suzuki T; Kohno K
    Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The concentration of end products of purine metabolism as possible signs of tissue hypoxia in critically ill surgical patients].
    Riabov GA; Ladygin SS; Azizov IuM
    Anesteziol Reanimatol; 1993; (4):41-3. PubMed ID: 8239027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel xanthine dehydrogenase inhibitor (BOF-4272).
    Sato S; Tatsumi K; Nishino T
    Adv Exp Med Biol; 1991; 309A():135-8. PubMed ID: 1789192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.